MULROY MICHAEL H. (President and CEO) purchased 3.2% of their position (2.95K shares) of ASTERIAS BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/27/2018ACC: 0001140361-18-033875
DirectorOfficer· President and CEO
Since Jul 2018
+2.95K
Net shares
Net buyer
$5.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.95K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.95K
Price / share
$1.69
Trade value
$5K
% of position
3.2%
7/25/2018
91.51K→94.46K
Total
Net shares
+2.95K
Net value
$5K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/25/2018 | P · Purchase | +2.95K | $1.69 | $5K | 3.2% | 91.51K | 94.46K |
| Total | +2.95K | $5K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)2
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
200K
Shares owned
200K
Exercise price
1.95
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
800K
Shares owned
800K
Exercise price
3.7
Expiration
—
Exercise window
—
Total
Underlying
1M
Owned
1M
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 1.95 | — | — | 200K | 200K |
| Stock Options Direct | Common Stock | 3.7 | — | — | 800K | 800K |
| Total | 1M | 1M | ||||